Emmaus Life Sciences, Inc. (EMMA)

Emmaus Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1	1	6	13	82	60
Market Cap Growth	-87.15%	-91.23%	-52.02%	-84.34%	36.67%	-36.90%
Enterprise Value	32	32	39	42	103	42
Last Close Price	0.01	0.01	0.10	0.26	1.67	1.23
PE Ratio	-	-	-	-	-	44.50
Forward PE	-	-	-	4.34	-	-
PS Ratio	0.05	0.03	0.21	0.70	4.00	2.60
PB Ratio	-0.01	-0.01	-0.13	-0.38	-3.84	-11.68
EV/Sales Ratio	2.30	1.91	1.31	2.27	4.99	1.82
EV/EBITDA Ratio	-	-	10.85	-	-	1503.76
EV/EBIT Ratio	-	-	10.95	-	-	-
Debt / Equity Ratio	-0.58	-0.58	-0.70	-0.90	-1.04	-3.68
Debt / EBITDA Ratio	-	-	7.05	-	-	15.45
Asset Turnover	0.57	0.57	0.71	0.35	0.36	0.39
Inventory Turnover	0.73	0.72	0.66	0.76	0.58	0.30
Quick Ratio	0.05	0.06	0.13	0.04	0.09	0.12
Current Ratio	0.08	0.11	0.19	0.12	0.25	0.48
Return on Assets (ROA)	-2.75%	-4.03%	5.31%	-7.84%	-6.59%	-0.03%
Return on Capital (ROIC)	-	-	-	-	-51.80%	-0.18%
Earnings Yield	-476.56%	-1188.71%	-60.31%	-82.36%	-19.36%	2.25%
FCF Yield	-301.76%	-423.32%	-24.56%	-39.53%	-1.61%	-4.09%
Buyback Yield / Dilution	-9.16%	-19.07%	-7.41%	-0.38%	-0.73%	-15.71%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.